Posts tagged Canaccord


Is it Time to Raise a White Flag on Nike Inc (NKE)? Canaccord Reigns in Expectations for Fiscal 2018

How long will investors still hold out patience for Nike after two years of a “stale innovation pipeline?”

Read more

Canaccord More Bullish Than Ever on Quidel Corporation (QDEL); Here’s Why

Analyst bumps up price target on QDEL on back of “sweetened” deal to acquire Alere’s BNP Assay segment.

Read more

Oncolytics Biotech Inc. (ONC) Stock Is Significantly De-Risked After End-of-Phase II Meeting with FDA, Cheers Canaccord

Analyst lifts price target on Oncolytics with new clarity from the FDA on Reolysin’s path forward to approval.

Read more

Oracle Corporation (ORCL) Is Taking a 4% Dip on FQ2:18 Cloud Growth Outlook; These Analysts Offer a Bullish Take

One top analyst raises price target on Oracle; another analyst believes the worst is now over for the giant.

Read more

Top Analyst Is Three Cheers for Apple Inc. (AAPL) to Bring in Strong iPhone Upgrade Sales

Analyst introduces new expectations for Apple to sell 233 million iPhones in 2019.

Read more

Canaccord Assumes a Speculative Buy on Aurinia Pharmaceuticals Inc (AUPH) Amid High Risk Factor for Biotech Drug Development

However, Aurinia’s not-so-secret lead drug asset Voclosporin offers a compelling partnering opportunity.

Read more

Top Analyst Spotlights Advanced Micro Devices, Inc. (AMD), NVIDIA Corporation (NVDA) and Intel Corporation (INTC) Following the Hot Chips Industry Symposium

AMD has good odds for reward; Nvidia’s GPU game is strong; but Intel’s PC segment is the real gamble.

Read more

This Analyst Sees 1035% Upside for Palatin Technologies, Inc. (PTN) Following New Deal with Fosun Pharma

PTN focusing on entering the EU market through partnerships, says analyst.

Read more

Synergy Pharmaceuticals Inc (SGYP) Has Encouraging Sustainability Through 2019 Thanks to $300 Million Debt Financing

Synergy protects “financial health” without the sacrifice of extra pressure on share price, says Canaccord.

Read more

Lululemon Athletica inc. (LULU) Strong Q2 Numbers Don’t Demonstrate a Rebound: Canaccord

The Risk/Reward Factor of Lulu’s EPS Stalling Growth Does Not Look Too Good, Fears Analyst

Read more